IDEXX Laboratories, Inc.
(NASDAQ:IDXX) stock rose Tuesday after the veterinary diagnostics company reported second-quarter results that topped Wall Street estimates and raised its full-year earnings outlook.
Companion Animal Diagnostics Fuel Growth The company reported second-quarter earnings of $4.27 per share, beating the analyst consensus estimate of $3.96.
Revenue increased 10% year over year to $1.217 billion, or 9% on an organic basis, exceeding the Street estimate of $1.201 billion.
Companion Animal Group revenue rose 9% to $1.118 billion, driven by an 11% increase in recurring diagnostics revenue, or 10% on an organic basis.
